Overall market sentiment has been high on Collegium Pharmaceutical Inc (COLL) stock lately. COLL receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.
Collegium Pharmaceutical Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on COLL!
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With COLL Stock Today?
Collegium Pharmaceutical Inc (COLL) stock is trading at $24.46 as of 12:22 PM on Thursday, Nov 9, an increase of $1.34, or 5.82% from the previous closing price of $23.11. The stock has traded between $23.44 and $24.52 so far today. Volume today is less active than usual. So far 173,442 shares have traded compared to average volume of 271,607 shares.
To screen for more stocks like Collegium Pharmaceutical Inc click here.
More About Collegium Pharmaceutical Inc
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. It is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release & immediate-release formulations of tapentadol.
Click Here to get the full Stock Report for Collegium Pharmaceutical Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
